TerminatedPhase 2NCT01475253
Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis
Studying Interstitial cystitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Allergan
- Principal Investigator
- Curtis Nickel, MD, MSN NPQueen's University/Kingston General Hospital/Ontario Canada
- Intervention
- Lidocaine Releasing Intravesical System - LiRIS®(drug)
- Enrollment
- 104 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2011 – 2012
Study locations (29)
- Clinical Trials of Arizona, Glendale, Arizona, United States
- Citrus Valley Medical Research, Inc, Glendora, California, United States
- Stanford University Department of Urology, Stanford, California, United States
- Genitourinary Surgical Consultants, Denver, Colorado, United States
- Women's Health Specialty Care, Farmington, Connecticut, United States
- Grove Hill Clinical Research, New Britain, Connecticut, United States
- Manatee Medical Research Institute, LLC, Bradenton, Florida, United States
- North Idaho Urology, Coeur d'Alene, Idaho, United States
- Idaho Urologic Center, Meridian, Idaho, United States
- First Urology, Jeffersonville, Indiana, United States
- Regional Urology LLC, Shreveport, Louisiana, United States
- Lahey Clinic Medical Center, Burlington, Massachusetts, United States
- Bay State Clinical Trials, Inc, Watertown, Massachusetts, United States
- Female Pelvic Medicine & Urogynecology, Grand Rapids, Michigan, United States
- William Beaumont Hospital, Royal Oak, Michigan, United States
- +14 more locations on ClinicalTrials.gov
Collaborators
TARIS Biomedical, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01475253 on ClinicalTrials.govOther trials for Interstitial cystitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT06752603A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial CystitisOno Pharmaceutical Co. Ltd
- RECRUITINGEARLY PHASE1NCT04734106Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial CystitisWake Forest University Health Sciences
- RECRUITINGNANCT06366269Acupuncture First for IC/BPSUniversity Hospitals Cleveland Medical Center
- RECRUITINGPHASE2NCT06394830Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)Vaneltix Pharma, Inc.
- RECRUITINGNCT06729151Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain SyndromeWalter Reed National Military Medical Center
- RECRUITINGNCT06719232Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical InstillationJahn Ferenc South Pest Teaching Hospital
- RECRUITINGPHASE2, PHASE3NCT06096597Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder SyndromeDavid Sheyn
- RECRUITINGNANCT06299683Pain Type and Interstitial Cystitis/Bladder Pain Syndrome TreatmentVanderbilt University Medical Center